Dr. Nathaniel Katz is considered one of the leading experts of treatment and clinical study design in pain clinical trials. He is a neurologist and pain management specialist with a distinguished career at Harvard Medical School, Brigham & Women’s Hospital and Dana Farber Cancer Institute. From 2000-2004 he served as Chair of the Advisory Committee, Anesthesia, Critical Care, and Addiction Products Division, United States FDA, during which time he completed a Master of Science in Biostatistics at Columbia University.
Dr. Katz founded Analgesic Solutions with the mission of modernizing the design and conduct of pain clinical trials to advance the “scientific quality” of pain clinical research, and empower effective treatments for patients. He is the Principal Consultant and scientific oversight at Analgesic Solutions.
``Our company recently initiated a phase III RCT in US. It was a very successful multi-center trial collaboration and I found there has always been strong teamwork between my team and Analgesic Solutions. Their dedicated efforts and passion toward this project was truly remarkable.``
Nicola Giordan - Head of Clinical Operations, Fidia Farmaceutici S.p.A.
``Analgesic Solutions was critical to the design, execution and interpretation of our entire clinical development program, from proof of concept, pivotal phase 3 trials, positive FDA advisory committee and ultimate drug approval. Quite simply, we were successful because of their expertise, shared vision and determination.``
Dr. Joe Stauffer - former Chief Medical Officer, Alpharma Pharmaceuticals